Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MBX Biosciences, Inc. (MBX) had Return on Tangible Equity of -5.37% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-23.52M |
|
-- |
|
-- |
|
$27.27M |
|
$-27.27M |
|
$3.75M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-27.27M |
|
$-27.20M |
|
46.58M |
|
46.58M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$448.54M |
|
$3.13M |
|
$4.17M |
|
$452.70M |
|
$14.57M |
|
-- |
|
$0.38M |
|
$14.95M |
|
$437.76M |
|
$437.76M |
|
$437.76M |
|
47.57M |
|
| Cash Flow Statement Financials | |
$-20.21M |
|
$-97.10M |
|
$87.44M |
|
$75.29M |
|
$45.42M |
|
$-29.87M |
|
$5.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
30.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.37% |
|
|
Return on Tangible Equity |
-5.37% |
-5.19% |
|
-5.37% |
|
$9.20 |
|
$-0.44 |
|
$-0.43 |
|